Search results
Results from the Go Local Guru Content Network
The cellphone-friendly website and "MYmta" app, currently in a beta test phase, show straphangers real-time subway, bus and commuter rail information that has been housed in separate apps.
The app is still in Beta testing, but will eventually succeed the MYmta app. The new app has schedules and service alerts for subways, buses, Long Island Rail Road and Metro-North Railroad all in ...
The Metropolitan Transportation Authority (MTA) provides local and express bus, subway, and commuter rail service in Greater New York, and operates multiple toll bridges and tunnels in New York City. The Metropolitan Transportation Authority ( MTA) is a public benefit corporation responsible for public transportation in the New York City ...
Mitoxantrone is a type II topoisomerase inhibitor; it disrupts DNA synthesis and DNA repair in both healthy cells and cancer cells by intercalation [6] [7] between DNA bases. It is also classified as an antibiotic. [8] Human topoisomerase II beta in complex with DNA and mitoxantrone. PDB entry 4g0v. [9]
Thymosin-β 4 is a major cellular constituent in many tissues. Its intracellular concentration may reach as high as 0.5 mM. [8] Following Thymosin α1, β 4 was the second of the biologically active peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. [9]
“With this MYmta pilot, bus customers can choose to space themselves out a bit more where capacity allows.” A video released by MTA shows how the app gives exact numbers of passengers on any ...
The MYmta user interface at beta launch. MYmta is a mobile application -based passenger information display system developed by the Metropolitan Transportation Authority (MTA) of New York City. A beta version of the app was launched on July 2, 2018, and as of June 2019 is still undergoing beta testing. While other applications exist which serve ...
The serotonin syndrome is a hyper serotonergic state, which can become fatal and is a side effect of serotonergic enhancing drugs. The symptoms of serotonin syndrome caused by 4-MTA are described in the Report on the Risk Assessment of 4-MTA
Adverse effects. The US label for dinutuximab carries black box warnings for life-threatening infusion reactions and neurotoxicity, as it causes severe neuropathic pain, and can cause severe sensory neuropathy and severe peripheral motor neuropathy. Dinutuximab beta also has these adverse effects.
11α-Hydroxyprogesterone (11α-OHP), or 11α-hydroxypregn-4-ene-3,20-dione is an endogenous steroid and metabolite of progesterone. [1] [2] [3] It is a weak antiandrogen , and is devoid of androgenic , estrogenic , and progestogenic activity.